Pharmabiz7h
Aakash Healthcare in association with ANVKA Foundation launches nationwide initiative to transform lives of children with bone deformities
Our Bureau, Mumbai Wednesday, March 12, 2025, 16:45 Hrs [IST] ...
Pharmabiz6h
Hudson Therapeutics announces Shaperon to initiate phase 2b part 2 clinical trial of a topically administered drug, NuGel
Cambridge, Massachusetts Wednesday, March 12, 2025, 18:00 Hrs [IST] ...
Pharmabiz6h
Allo Health raises Rs. 16 crore to expand India’s largest sexual health ecosystem
Allo Health raises Rs. 16 crore to expand India’s largest sexual health ecosystem: Our Bureau, Bengaluru Wednesday, March 12, 2025, 17:45 Hrs [IST] Allo Health, India’s leadin ...
Pharmabiz7h
Viking Therapeutics inks broad manufacturing pact with CordenPharma to support commercialization of VK2735
Viking Therapeutics inks broad manufacturing pact with CordenPharma to support commercialization of VK2735: San Diego Wednesday, March 12, 2025, 17:00 Hrs [IST] Viking Therapeutic ...
Pharmabiz13h
China NMPA approves Kelun-Biotech’s TROP2 antibody drug conjugate sac-TMT for marketing in second indication
Biotech’s TROP2 antibody drug conjugate sac-TMT for marketing in second indication: Chengdu, China Wednesday, March 12, 2025, 11:00 Hrs [IST] Sichuan K ...
Pharmabiz11h
Kenox Pharma partners with Lactiga for development of novel mucosal-targeted Secretory IgA therapies for immunodeficient patients
Kenox Pharma partners with Lactiga for development of novel mucosal-targeted Secretory IgA therapies for immunodeficient patients: Princeton, New Jersey Wednesday, March 12, 2025, ...
Pharmabiz9h
Caristo Diagnostics’ CaRi-Plaque technology, an AI-assisted image analysis application to aid the diagnosis of CAD receives US FDA 510(k) clearance
Stamford, Connecticut Wednesday, March 12, 2025, 15:00 Hrs [IST] ...
Pharmabiz10h
Labcorp to acquire select assets of BioReference Health's innovative oncology and related clinical testing services businesses
Burlington, North Carolina Wednesday, March 12, 2025, 14:00 Hrs [IST] ...
Pharmabiz8h
Alkem Labs launches generic empagliflozin and its combinations in India under the brand name “Empanorm”
Alkem Laboratories Ltd announced the launch of generic empagliflozin and its combinations in India under the brand name “Empanorm” at prices that are approximately 80% lower than the innovator ...
Pharmabiz12h
Novo Nordisk announces results from REDEFINE 2 trial of CagriSema in people with obesity and type 2 diabetes
Bagsværd, Denmark Wednesday, March 12, 2025, 12:00 Hrs [IST] ...
Pharmabiz15h
Merck opens new, $1 billion, 225,000-sq ft facility dedicated to vaccine manufacturing at its Durham, North Carolina, site
Merck opens new, $1 billion, 225,000-sq ft facility dedicated to vaccine manufacturing at its Durham, North Carolina, site: Durham, North Carolina Wednesday, March 12, 2025, 09:00 ...
Pharmabiz8h
Boehringer Ingelheim partners with Veeva to launch ‘One Medicine Platform’
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, and Veeva Systems, global leader in cloud software for the life sciences industry, have announced the launch ...